Immunotherapy for Alzheimer's disease
- 1 April 2003
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 2 (4) , 215-220
- https://doi.org/10.1016/s1474-4422(03)00349-1
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Amyloid pores from pathogenic mutationsNature, 2002
- Phases of Aβ-deposition in the human brain and its relevance for the development of ADNeurology, 2002
- The Search for γ-Secretase and Development of InhibitorsCurrent Medicinal Chemistry, 2002
- β-Secretase as a Therapeutic Target for Inhibitor DrugsCurrent Medicinal Chemistry, 2002
- Alzheimers Disease: An Overview of Current and Emerging Therapeutic StrategiesCurrent Topics in Medicinal Chemistry, 2002
- Alzheimer’s disease and oxygen radicals: new insightsBiochemical Pharmacology, 2002
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999
- Translating cell biology into therapeutic advances in Alzheimer's diseaseNature, 1999
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991